Efficacy of Cefepime Continuous Infusion Versus an Intermittent Dosing Regimen
Status:
Completed
Trial end date:
2007-12-01
Target enrollment:
Participant gender:
Summary
To determine the efficacy of the administration of 7 to 14 days of cefepime in a continuous
infusion vs an intermittent (every 8 hours) administration, in adult patients hospitalized in
Bogotá with sepsis and bacteremia caused by gram negative bacilli. The outcome was the rate
of clinical cure and microbiological cure after 7 and 14 days of initiation of therapy and
rates of relapse after 28 days.
Hypothesis: The administration of beta lactams in continuous infusion allows a clinical or
microbiological cure greater than the intermittent administration.
Phase:
Phase 4
Details
Lead Sponsor:
Javeriana University
Collaborators:
Asociacion Colombiana de Infectologia, ACIN. Infectious Diseases Society of Colombia Clinica Palermo, Bogota Fundación San Carlos, Bogota Hospital san Jorge, Pereira Hospital san Juan de Dios, Antioquia Hospital Santa Clara, Bogota Hospital Simon Bolivar, Bogota